Toxic Epidermal Necrolysis

Pediatric Derm Emergencies & How to Treat Them
pediatric dermatologyNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Kalyani Marathe, director of the dermatology division at Cincinnati Children’s Hospital. Dr. Marathe shares serious pediatric skin issues including infections, drug reactions and congenital conditions. Watch and learn how to recognize and treat these serious issues, and how to know whe …
pediatric dermatology
JDD Issue Highlights | May 2022
MohsThe May 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and features other topics such as fungal infections, updates on new topical advances, and Mohs micrographic surgery. We share this month’s issue highlights straight from the JDD Editor’s desk: Insights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes concludes …
Mohs
Widespread Skin Necrosis Secondary to Gemcitabine Therapy
Skin Necrosis INTRODUCTION Cutaneous side effects are relatively common in chemotherapy but vary in frequency and severity depending on the medication, dose, duration, pharmacokinetics, and pharmacodynamics. Gemcitabine, a pyrimidine nucleoside analogue, is a common oncologic agent used in the treatment of a variety of malignancies such as cancers of the head and neck, lung cancer, breast cancer, pancreatic …
Skin Necrosis
Drug Re-exposure in Toxic Epidermal Necrolysis
Toxic Epidermal Necrolysis podcastWe’ve all been there – that dreaded middle of the night page/call from the ER. Three simple words that send us spinning: “Rule out TEN.” Have no fear though, because the skin sloughing savoir is here. Inpatient dermatology service director Dr. Helena Pasieka joined JDD podcast host Dr. Adam Friedman to discuss her recent research that elucidates opportunities to prevent offending agent re- …
Toxic Epidermal Necrolysis podcast